Patent directory · USPTO A61K / A61P
Patents matching “XBIOTECH INC.”
29 pharma patents match "XBIOTECH INC." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 29 pharmaceutical patents matching "XBIOTECH INC." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12116405
Arthritis treatment
granted -
US 11932688
Treatment for neoplastic diseases
granted -
US 11773157
Compositions and methods for treating and preventing Staphylococcus aureus infections
granted -
US 11370831
Compositions and methods for treating and preventing Staphylococcus aureus infections
granted -
US 10577410
Compositions and methods for treating and preventing Staphylococcus aureus infections
granted -
US 10294296
Treatment for neoplastic diseases
granted -
US 10214581
Compositions and methods for treating and preventing Staphylococcus aureus infections
granted -
US 10202449
Cachexia treatment
granted -
US 9988447
Treatment of diabetes
granted -
US 9902769
Treatment of dermatological pathologies
granted -
US 9840558
Human antibody specific for interleukin-1alpha
granted -
US 9809649
Cachexia treatment
granted -
US 9783598
Compositions and methods for treating and preventing Staphylococcus aureus infections
granted -
US 9724409
Treatment of inflammatory skin disease
granted -
US 9545441
Treatment of diabetes
granted -
US 9486523
Compositions and methods for treating and preventing Staphylococcus aureus infections
granted -
US 9416172
Compositions and methods for treating and preventing Staphylococcus aureus infections
granted -
US 9181338
Human antibody specific for IL-1alpha
granted -
US 8962814
Interleukin-1α antibodies and methods of use
granted -
US 8956831
Nucleic acids encoding a human monoclonal antibody that specifically binds to IL-1α
granted -
US 8865175
Increasing anti-IL-1α antibodies in a subject
granted -
US 8784817
Method for killing IL-1 alpha expressing cells
granted -
US 8679489
Inhibiting cell migration
granted -
US 8546331
Modulation of pathogenic CD14+/CD16+ monocytes
granted